Sep 17, 2026, 10:54 AM EDT · 16 days ago BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Ruger & Company, Inc. (NYSE – RGR), Atkore, Inc. (NYSE – ATKR), Centerspace (NYSE – CSR), Aethlon Medical, Inc. (Nasdaq – AEMD) ATKR CSR RGR
2026-09-17T12:07:56.000Z · 16 days ago M&A News: Aethlon Medical Stock (AEMD) Rockets 400% After North Immunology Deal to Fight Eczema
Sep 17, 2026, 6:30 AM EDT · 16 days ago Aethlon Medical & North Immunology Announce Merger to Advance Novel IL-13 x IL-18 Bispecific Antibody for Atopic Dermatitis
Aug 13, 2026, 4:15 PM EDT · 7 weeks ago Aethlon Medical Reports Q1 Fiscal 2027 Results and Progress on Hemopurifier® Program
Aug 5, 2026, 8:01 AM EDT · 1 month ago Aethlon Medical to Release First Quarter Financial Results and Host Conference Call on August 13, 2026
2026-07-13T12:06:26.000Z · 2 months ago Aethlon Medical announces results from Hemopurifier trial in Australia
Jul 13, 2026, 8:01 AM EDT · 2 months ago Aethlon Medical Continues to Observe Directional Changes in Second Cohort of Australian Oncology Clinical Trial Evaluating Hemopurifier®
Jul 6, 2026, 9:25 AM EDT · 2 months ago Aethlon Medical Announces Pricing of $4.0 Million Follow-On Offering Priced At-The-Market Under NASDAQ Rules
2026-06-26T12:10:25.000Z · 3 months ago Aethlon Medical announces publication demonstrating potential of Hemopurifier
Jun 26, 2026, 8:01 AM EDT · 3 months ago Aethlon Medical Announces Publication Demonstrating Novel Long COVID Biomarker and Potential Therapeutic Target for the Hemopurifier®
2026-06-22T13:22:29.000Z · 3 months ago Aethlon Medical files to sell 6M shares of common stock, warrants
Jun 10, 2026, 4:15 PM EDT · 3 months ago Aethlon Medical Announces Fiscal Year End March 31, 2026 Financial Results and Corporate Update
Jun 2, 2026, 8:01 AM EDT · 4 months ago Aethlon Medical to Release Fiscal Year End Financial Results and Host Conference Call on June 10, 2026
May 21, 2026, 8:01 AM EDT · 4 months ago Aethlon Medical Monitoring Current Ebola Outbreak and Reaffirms Outbreak/Pandemic Preparedness
Mar 24, 2026, 10:30 AM EDT · 6 months ago Advancements in Novel Immunotherapeutics in The Oncology Battle
2026-03-24T12:11:30.000Z · 6 months ago Aethlon Medical advances to final cohort in AEMD-2022-06 trial
Mar 24, 2026, 8:01 AM EDT · 6 months ago Aethlon Medical, Inc. Advances to Final Cohort in Oncology Clinical Trial Following Positive DSMB Review
Mar 12, 2026, 8:01 AM EDT · 6 months ago Aethlon Medical Engages Maxim Group LLC to Evaluate Strategic Opportunities
Mar 6, 2026, 8:35 AM EST · 7 months ago Aethlon Medical to Present at the Life Sciences Investor Forum on March 12th
Feb 23, 2026, 8:01 AM EST · 7 months ago Aethlon Medical to Present on the Emerging Growth Conference on February 25th 2026
2026-02-12T21:22:12.000Z · 7 months ago Aethlon Medical reports Q3 EPS ($2.45) vs. ($10.05) last year
Feb 12, 2026, 4:15 PM EST · 7 months ago Aethlon Medical Announces Fiscal Q3 2026 Financial Results and Corporate Update
Feb 4, 2026, 8:01 AM EST · 8 months ago Aethlon Medical to Release Fiscal Third Quarter Financial Results and Host Conference Call on February 12, 2026
2026-01-07T21:21:45.000Z · 8 months ago Aethlon Medical files to sell 2.03M shares of common stock for holders
Dec 5, 2025, 9:15 AM EST · 10 months ago Aethlon Medical Announces Pricing of a Private Placement and Warrant Inducement, Priced At-The-Market for Aggregate Gross Proceeds of $3.3 Million
2025-12-02T13:10:50.000Z · 10 months ago Aethlon Medical’s Hemopurifier shows potential efficacy in long COVID
Dec 2, 2025, 8:01 AM EST · 10 months ago Aethlon Medical Announces Publication of Preclinical Data Showing That the GNA Affinity Resin in the Hemopurifier® Binds to Extracellular Vesicles in Long COVID patient samples and Decreases Inflammatory microRNAs
2025-11-12T21:26:43.000Z · 10 months ago Aethlon Medical reports Q2 EPS ($3.74) vs. ($16.11) last year
Nov 12, 2025, 4:15 PM EST · 10 months ago Aethlon Medical Announces Fiscal Q2 2025 Financial Results and Corporate Update
Nov 7, 2025, 8:01 AM EST · 11 months ago Aethlon Medical to Release Fiscal Second Quarter Financial Results and Host Conference Call on November 12, 2025
Oct 7, 2025, 8:01 AM EDT · 12 months ago Aethlon Medical's Hemopurifier® shows Changes in Extracellular Vesicles, Extracellular MicroRNAs, and T Cell Numbers in Australian Oncology Clinical Trial
2025-09-04T13:25:35.000Z · 1 year ago Aethlon Medical announces pricing of $4.5M common stock, warrant offering
Sep 4, 2025, 9:15 AM EDT · 1 year ago Aethlon Medical Announces Pricing of $4.5 Million Public Offering
2025-09-03T12:11:26.000Z · 1 year ago Aethlon Medical announces issuance of patents protecting Hemopurifier
Sep 3, 2025, 8:01 AM EDT · 1 year ago Aethlon Medical Announces Issuance of Hemopurifier® Patents for the Treatment of Long COVID and COVID-19-associated Coagulopathy (CAC)
Aug 13, 2025, 4:15 PM EDT · 1 year ago Aethlon Medical Announces Financial Results for the Fiscal First Quarter Ended June 30, 2025, and Provides Corporate Update
Aug 5, 2025, 8:01 AM EDT · 1 year ago Aethlon Medical to Release Fiscal First Quarter Financial Results and Host Conference Call on August 13, 2025
Jul 15, 2025, 8:01 AM EDT · 1 year ago Aethlon Medical, Inc. Announces Positive Data Safety Monitoring Board Review and Recommendation to Advance to Next Clinical Trial Cohort
Jun 26, 2025, 4:15 PM EDT · 1 year ago Aethlon Medical Announces Financial Results for the Fiscal Fourth Quarter Ended March 31, 2025, and Provides Corporate Update
Jun 20, 2025, 8:01 AM EDT · 1 year ago Aethlon Medical to Release Fiscal Fourth Quarter Financial Results and Host Conference Call on June 26, 2025
Jun 18, 2025, 8:01 AM EDT · 1 year ago Aethlon Medical Treats Second Patient in Australian Hemopurifier® Cancer Trial
Jun 9, 2025, 8:01 AM EDT · 1 year ago Aethlon Medical to Present New Pre-Clinical Data at the Keystone Symposium on Long COVID and Other Post-Acute Infection Syndromes
May 14, 2025, 8:01 AM EDT · 1 year ago Aethlon Medical Announces Publication of Preclinical Data Showing Ability of the Hemopurifier® to Remove Platelet-Derived Extracellular Vesicles from Plasma
Mar 10, 2025, 8:01 AM EDT · 1 year ago Aethlon Medical Publishes Preclinical Data on the Hemopurifier® in Transplant Immunology Journal
Feb 13, 2025, 8:01 AM EST · 1 year ago Aethlon Medical to Present at the Emerging Growth Conference on February 19, 2025
Feb 12, 2025, 4:15 PM EST · 1 year ago Aethlon Medical Announces Financial Results for the Fiscal Third Quarter Ended December 31, 2024 and Provides Corporate Update
Feb 5, 2025, 8:01 AM EST · 1 year ago Aethlon Medical to Release Fiscal Third Quarter Financial Results and Host Conference Call on February 12, 2025
Jan 29, 2025, 8:01 AM EST · 1 year ago Aethlon Medical Treats First Patient in Australian Hemopurifier® Cancer Trial
Dec 20, 2024, 8:01 AM EST · 1 year ago Aethlon Medical Provides Update on the Ability of Its Hemopurifier® to Capture H5N1 Bird Flu
Nov 14, 2024, 8:00 AM EST · 1 year ago Biotech and Medical Tech Stocks Report Significant Updates in the Race for Cancer Treatments as Cancer Rates Rise Globally
Nov 13, 2024, 4:15 PM EST · 1 year ago Aethlon Medical Announces Financial Results for the Fiscal Second Quarter Ended September 30, 2024 and Provides Corporate Update
Nov 12, 2024, 8:00 AM EST · 1 year ago Innovative Medical Technology Advances with First Patient Enrollments
Nov 11, 2024, 8:01 AM EST · 1 year ago Aethlon Medical Reaches Key Milestone with Enrollment of the First Patient in (FPI) Its Hemopurifier® Cancer Trial in Australia
Nov 6, 2024, 8:01 AM EST · 1 year ago Aethlon Medical to Release Fiscal Second Quarter Financial Results and Host Conference Call on November 13, 2024
Oct 8, 2024, 8:01 AM EDT · 1 year ago Aethlon Medical to Participate in the 2024 Maxim Healthcare Virtual Summit
Sep 19, 2024, 10:00 AM EDT · 2 years ago Immunotherapy Clinical Trials - A New Approach to Treating Cancer
Sep 19, 2024, 8:01 AM EDT · 2 years ago Aethlon Receives Ethics Committee Approval for Hemopurifier® Cancer Trial in India
Sep 17, 2024, 8:01 AM EDT · 2 years ago Aethlon Medical to Present at Virtual Investor Conferences in September
Sep 16, 2024, 8:01 AM EDT · 2 years ago Aethlon Medical Announces Activation of Royal Adelaide Hospital to Begin Patient Screening and Enrollment in Hemopurifier® Cancer Trial